27. PULMONARY SCLEROSING PNEUMOCYTOMA: CASE REPORT

Ngo Vi Hai1, Le Hai Son1, Nguyen Van Xuan Ha1, Nguyen Duc Thang1, Dang Trung Dung1, Nguyen Manh Tuong1, Dao Thi Huyen1
1 108 Military Central Hospital

Main Article Content

Abstract

Introduction: The issue at hand revolves around Pulmonary Sclerosing Pneumocytoma (PSP), a rare benign lung lesion predominantly found in Asian women. The rarity of this condition and its vague clinical characteristics pose challenges in the diagnostic process.


Objective: This article aims to comprehensively report a case of PSP, providing an evaluation of imaging diagnostics, biopsy, and surgical intervention. The primary goals include contributing to scientific data, as well as sharing insights into the diagnostic and treatment processes.


Case Report: A 36-year-old female patient was incidentally discovered to have a left lung mass during a routine health examination. The diagnostic approach involved CT, PET/CT, core biopsy, and video-assisted thoracoscopic surgery for tumor resection. Immunohistochemical staining of the tissue confirmed the distinctive features of PSP.


Discussion: The discussion centers on the diagnostic characteristics of PSP, the challenges in distinguishing it from malignant lesions, and the strategic considerations for surgical intervention. Emphasis is placed on the rarity of PSP and underscores the significance of accurate diagnosis.


Conclusion: Summarizing insights from the case report and discussion, the conclusion underscores the critical importance of precise diagnosis and effective treatment strategies for PSP. Encouragement is given for further research and long-term monitoring to deepen our understanding of this uncommon pathology.

Article Details

References

[1] Liebow AA, DS Hubbell, Sclerosing hemangioma
(histiocytoma, xanthoma) of the lung; Cancer,
9(1), 1956, p. 53-75.
[2] Travis WD et al., The 2015 World Health
Organization Classification of Lung Tumors:
Impact of Genetic, Clinical and Radiologic
Advances Since the 2004 Classification; J Thorac
Oncol, 10(9), 2015, p. 1243-1260.
[3] Zhu J, Analysis of the clinical differentiation of
pulmonary sclerosing pneumocytoma and lung
cancer, J Thorac Dis 2017;9(9):2974-2981. doi:
10.21037/jtd.2017.08.07
[4] Who classification of Tumour: Thoracic
Tumours, the WHO Classification of Editorial
Board, IARC, 2021, 5, 555.
[5] De Luca G, Martucci N, Setola S et al., Sclerosing
hemangioma of the lung mimicking pulmonary
metastasis; Lung 2015; 193: 447-8.
[6] Park JS et al., Surgery for Pulmonary Sclerosing
Hemangioma: Lobectomy versus Limited
Resection; Korean J Thorac Cardiovasc Surg,
44(1), 2011, p. 39-43.
[7] Rivera E et al., Pulmonary Sclerosing
Pneumocytoma; J Bronchology Interv Pulmonol,
25(4), 2018, p. e54-e56.